-+ 0.00%
-+ 0.00%
-+ 0.00%
MGC Diagnostics Partners With Monitored Therapeutics to Expand Point-of-Care Spirometry
Share
Listen to the news
MGC Diagnostics Partners With Monitored Therapeutics to Expand Point-of-Care Spirometry
  • MGC Diagnostics partnered with Monitored Therapeutics on November 12, 2026, to expand connected spirometry beyond pulmonary laboratories.
  • Under the agreement, MGC will sell and support GoSpiro and GoClinic for US healthcare organizations.
  • The solution connects with Ascent Software Solutions to centralize clinical review and reporting of point-of-care spirometry results.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MGC Diagnostics Corporation published the original content used to generate this news brief on November 12, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending